{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:52:55Z","timestamp":1785891175079,"version":"3.56.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000052","name":"National Institutes of Health Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jconrel.2024.04.029","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T20:55:35Z","timestamp":1713905735000},"page":"110-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis"],"prefix":"10.1016","volume":"370","author":[{"given":"Himanshu N.","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimpy","family":"Diwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor L.","family":"Estevao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep K.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Nurunnabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.04.029_bb0005","doi-asserted-by":"crossref","unstructured":"Pathogenesis of Systemic Sclerosis: Recent Insights of Molecular and Cellular Mechanisms and Therapeutic Opportunities - John Varga, Maria Trojanowska, Masataka Kuwana, 2017, (n.d.). https:\/\/doi.org\/10.5301\/jsrd.5000249 (accessed November 29, 2023).","DOI":"10.5301\/jsrd.5000249"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0010","unstructured":"Emerging targets of disease-modifying therapy for systemic sclerosis Nat. Rev. Rheumatol., (n.d.). https:\/\/www.nature.com\/articles\/s41584-019-0184-z (accessed November 29, 2023)."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0015","unstructured":"Scleroderma Facts, n.d. https:\/\/scleroderma.org\/wp-content\/uploads\/2022\/02\/SIP-2022-Updated-7_5_2022.pdf."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.it.2005.09.004","article-title":"Scleroderma: from cell and molecular mechanisms to disease models","volume":"26","author":"Abraham","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.burns.2013.11.010","article-title":"New molecular medicine-based scar management strategies","volume":"40","author":"Arno","year":"2014","journal-title":"Burns"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00011-015-0806-0","article-title":"Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis","volume":"64","author":"Huang","year":"2015","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0035","doi-asserted-by":"crossref","unstructured":"Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: A novel mouse model for scleroderma? Wei - 2011 - Arthritis Rheumat Wiley Online Library, (n.d.). https:\/\/doi.org\/10.1002\/art.30312 (accessed November 29, 2023).","DOI":"10.1002\/art.30312"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0040","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00018-015-2110-0","article-title":"The myofibroblast, a key cell in normal and pathological tissue repair","volume":"73","author":"Darby","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0045","unstructured":"Myofibroblasts and mechano-regulation of connective tissue remodelling | Nat. Rev. Mol. Cell Biol., (n.d.). https:\/\/www.nature.com\/articles\/nrm809 (accessed November 29, 2023)."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0050","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1186\/ar2080","article-title":"Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes","volume":"8","author":"Bauer","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.cellbio.19.011102.111135","article-title":"Cadherins as modulators of cellular phenotype","volume":"19","author":"Wheelock","year":"2003","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0060","first-page":"947","article-title":"Cadherin-11 is expressed in invasive breast Cancer cell Lines1","volume":"59","author":"Pishvaian","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0065","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1091\/mbc.e04-05-0386","article-title":"Myofibroblast development is characterized by specific cell-cell Adherens junctions","volume":"15","author":"Hinz","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0070","unstructured":"Epithelial-Mesenchymal Transitions: Twist in Development and Metastasis - ScienceDirect, (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0092867404007020 (accessed November 30, 2023)."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0075","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1137306","article-title":"Cadherin-11 in synovial lining formation and pathology in arthritis","volume":"315","author":"Lee","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0080","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20041545","article-title":"Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes","volume":"200","author":"Valencia","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3835(95)04047-1","article-title":"Simultaneous expression of cadherin-11 in signet-ring cell carcinoma and stromal cells of diffuse-type gastric cancer","volume":"99","author":"Shibata","year":"1996","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/dbio.1995.1148","article-title":"Cloning and expression analysis of a novel mesodermally expressed cadherin","volume":"169","author":"Hoffmann","year":"1995","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0095","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1242\/jcs.024877","article-title":"Fibrogenic fibroblasts increase intercellular adhesion strength by reinforcing individual OB-cadherin bonds","volume":"121","author":"Pittet","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0100","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type-specific gene expression patterns in scleroderma skin","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0105","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.21894","article-title":"Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts","volume":"54","author":"Gardner","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0110","doi-asserted-by":"crossref","unstructured":"Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-\u03b2 production and epithelial to mesenchymal transition. Schneider - 2012 - FASEB J. Wiley Online Library, (n.d.). https:\/\/doi.org\/10.1096\/fj.11-186098 (accessed November 29, 2023).","DOI":"10.1096\/fj.11-186098"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0115","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.38275","article-title":"Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis","volume":"66","author":"Wu","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0120","unstructured":"Fibrosis\u2014a lethal component of systemic sclerosis | nature reviews Rheumatology, (n.d.). https:\/\/www.nature.com\/articles\/nrrheum.2014.53 (accessed November 29, 2023)."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0125","unstructured":"JCI - Systemic Sclerosis: A Prototypic Multisystem Fibrotic Disorder, (n.d.). https:\/\/www.jci.org\/articles\/view\/31139 (accessed November 29, 2023)."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0130","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1172\/JCI66700","article-title":"Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis","volume":"123","author":"Zhou","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0135","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","article-title":"State-of-the-art evidence in the treatment of systemic sclerosis","volume":"19","author":"Pope","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000000357","article-title":"Surgical excision with adjuvant irradiation for treatment of keloid scars: a systematic review","volume":"3","author":"van Leeuwen","year":"2015","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0145","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000000348","article-title":"Intralesional cryotherapy for the treatment of keloid scars: evaluating effectiveness","volume":"3","author":"van Leeuwen","year":"2015","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0150","doi-asserted-by":"crossref","unstructured":"Full article: Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients, (n.d.). https:\/\/doi.org\/10.3109\/09546634.2014.906034 (accessed November 30, 2023).","DOI":"10.3109\/09546634.2014.906034"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0155","unstructured":"Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00664352 (accessed November 30, 2023)."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0160","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1080\/10428194.2020.1845332","article-title":"Safety and efficacy of navitoclax, a BCL-2 and BCL-XL inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study","volume":"62","author":"de Vos","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0165","first-page":"131","article-title":"A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts, nanomedicine: nanotechnology","volume":"12","author":"Chen","year":"2016","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0170","doi-asserted-by":"crossref","unstructured":"Targeting of cadherin-11 decreases skin fibrosis in the tight skin-1 mouse model. PLOS ONE, (n.d.). https:\/\/doi.org\/10.1371\/journal.pone.0187109 (accessed November 29, 2023).","DOI":"10.1371\/journal.pone.0187109"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0175","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.cclet.2021.01.001","article-title":"STING-activating drug delivery systems: design strategies and biomedical applications","volume":"32","author":"Li","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0180","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.colsurfb.2008.11.033","article-title":"Modulation of the physicochemical state of interior agents to prepare controlled release liposomes","volume":"69","author":"Wang","year":"2009","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0185","unstructured":"Diversity of PEGylation methods of liposomes and their influence on RNA delivery. MedChemComm (RSC Publishing), (n.d.). https:\/\/pubs.rsc.org\/en\/content\/articlelanding\/2019\/md\/c8md00515j (accessed November 30, 2023)."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0190","doi-asserted-by":"crossref","first-page":"17648","DOI":"10.1039\/D1NR04659D","article-title":"Development of site-specific antibody-conjugated immunoliposomes for sensitive detection of disease biomarkers","volume":"13","author":"Zhang","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0195","doi-asserted-by":"crossref","unstructured":"Endothelin 1 contributes to the effect of transforming growth factor \u03b21 on wound repair and skin fibrosis. Lagares - 2010 - Arthritis Rheumat. Wiley Online Library, (n.d.). https:\/\/doi.org\/10.1002\/art.27307 (accessed November 29, 2023).","DOI":"10.1002\/art.27307"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-020-00341-8","article-title":"The Janus-like role of proline metabolism in cancer","volume":"6","author":"Burke","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0205","doi-asserted-by":"crossref","unstructured":"The role of collagen in cancer: from bench to bedside. J. Translat. Med., (n.d.). https:\/\/doi.org\/10.1186\/s12967-019-2058-1 (accessed November 29, 2023).","DOI":"10.1186\/s12967-019-2058-1"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0210","doi-asserted-by":"crossref","unstructured":"Intracellular hydroxyproline imprinting following resolution of bleomycin-induced pulmonary fibrosis. Eur. Respir. Soc., (n.d.). https:\/\/erj.ersjournals.com\/content\/59\/5\/2100864 (accessed November 29, 2023).","DOI":"10.1183\/13993003.00864-2021"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/0250-474X.65014","article-title":"Design and evaluation of liposomal formulation of pilocarpine nitrate","volume":"72","author":"Rathod","year":"2010","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0220","unstructured":"Effect of phospholipids on membrane characteristics and storage stability of liposomes. ScienceDirect, (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1466856422002405 (accessed November 30, 2023)."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0225","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0230","doi-asserted-by":"crossref","unstructured":"Myofibroblasts: function, formation, and scope of molecular therapies for skin fibrosis, Biomolecules. (n.d.). https:\/\/www.mdpi.com\/2218-273X\/11\/8\/1095 (accessed November 29, 2023).","DOI":"10.3390\/biom11081095"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0235","doi-asserted-by":"crossref","unstructured":"Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis. Sci. Translat. Med., (n.d.). https:\/\/doi.org\/10.1126\/scitranslmed.aal3765 (accessed November 29, 2023).","DOI":"10.1126\/scitranslmed.aal3765"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0240","unstructured":"BCL-2 is dispensable for thrombopoiesis and platelet survival. Cell Death Dis., (n.d.). https:\/\/www.nature.com\/articles\/cddis201597 (accessed November 29, 2023)."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0245","doi-asserted-by":"crossref","unstructured":"Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. Sci. Translat. Med., (n.d.). https:\/\/doi.org\/10.1126\/scitranslmed.aaa4642 (accessed November 29, 2023).","DOI":"10.1126\/scitranslmed.aaa4642"},{"key":"10.1016\/j.jconrel.2024.04.029_bb0250","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphys.2018.00113","article-title":"Neutrophil: a cell with many roles in inflammation or several cell types?","volume":"9","author":"Rosales","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-62703-845-4_1","article-title":"The role of neutrophils in the immune system: an overview","volume":"1124","author":"Malech","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0260","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1034\/j.1600-065X.2002.18602.x","article-title":"Integration of inflammatory signals by rolling neutrophils","volume":"186","author":"Ley","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0265","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic cell migration in inflammation and immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0270","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-011-0215-5","article-title":"Dendritic cells: novel players in fibrosis and scleroderma","volume":"14","author":"Lu","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.843342","article-title":"Depletion and dysfunction of dendritic cells: understanding SARS-CoV-2 infection","volume":"13","author":"Chang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.04.029_bb0280","doi-asserted-by":"crossref","unstructured":"Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery. Zhang - 2022 \u2013 J. Biomed. Mater. Res. Part A Wiley Online Library, (n.d.). https:\/\/doi.org\/10.1002\/jbm.a.37356 (accessed April 7, 2024).","DOI":"10.1002\/jbm.a.37356"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924002505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924002505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T08:07:41Z","timestamp":1740211661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924002505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":56,"alternative-id":["S0168365924002505"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.04.029","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}